Fig. 2From: Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinomaKaplan-meier estimates of a) progression free survival (PFS) and b) overall survival (OS) grouped by CRP level. The normal CRP (≤ 10 mg/L) cohort showed significantly improved PFS and OS compared with patients with elevated CRPBack to article page